Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines.

[1]  M. Bennett,et al.  Oxycodone for cancer-related pain. , 2022, The Cochrane database of systematic reviews.

[2]  P. Larkin,et al.  Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines† , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  C. Centeno,et al.  Delirium in adult cancer patients: ESMO Clinical Practice Guidelines† , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  W. Leppert,et al.  Oral Prolonged‐Release Oxycodone/Naloxone for Managing Pain and Opioid‐Induced Constipation: A Review of the Evidence , 2018, Pain practice : the official journal of World Institute of Pain.

[5]  J. Norrie,et al.  Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain , 2018, JAMA oncology.

[6]  G. Murray,et al.  Pain Management in Cancer Center Inpatients: A Cluster Randomized Trial to Evaluate a Systematic Integrated Approach—The Edinburgh Pain Assessment and Management Tool , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Tsutsumi,et al.  Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Megan E O'Brien,et al.  Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report , 2017, The Lancet.

[9]  M. Fallon,et al.  Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain. , 2017, Journal of pain and symptom management.

[10]  P. Wiffen,et al.  Oral paracetamol (acetaminophen) for cancer pain. , 2017, The Cochrane database of systematic reviews.

[11]  P. Wiffen,et al.  Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. , 2017, The Cochrane database of systematic reviews.

[12]  P. Wiffen,et al.  Opioids for cancer pain - an overview of Cochrane reviews. , 2017, The Cochrane database of systematic reviews.

[13]  E. Kalso,et al.  Ketamine as an adjuvant to opioids for cancer pain. , 2017, The Cochrane database of systematic reviews.

[14]  W. Kremers,et al.  A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR , 2017, European journal of pain.

[15]  K. Hopkins,et al.  SCORAD III: Randomized noninferiority phase III trial of single-dose radiotherapy (RT) compared to multifraction RT in patients (pts) with metastatic spinal canal compression (SCC). , 2017 .

[16]  M. Fallon,et al.  Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies , 2017, British journal of pain.

[17]  S. Derry,et al.  Tramadol with or without paracetamol (acetaminophen) for cancer pain. , 2017, The Cochrane database of systematic reviews.

[18]  W. Kremers,et al.  Long‐term efficacy and safety of oxycodone‐naloxone prolonged‐release formulation (up to 180/90 mg daily) – results of the open‐label extension phase of a phase III multicenter, multiple‐dose, randomized, controlled study , 2017, European journal of pain.

[19]  P. Notaro,et al.  High dosage of a fixed combination oxycodone/naloxone prolonged release: efficacy and tolerability in patients with chronic cancer pain , 2017, Supportive Care in Cancer.

[20]  I. Tracey.  Neuroimaging mechanisms in pain: from discovery to translation. , 2017, Pain.

[21]  A. Graeff,et al.  Pharmacological Treatment of Pain in Cancer Patients: The Role of Adjuvant Analgesics, a Systematic Review , 2017, Pain practice : the official journal of World Institute of Pain.

[22]  B. Laird,et al.  The use of opioids in cancer patients with renal impairment—a systematic review , 2017, Supportive Care in Cancer.

[23]  P. Alonso-Coello,et al.  WITHDRAWN: Radioisotopes for metastatic bone pain. , 2017, The Cochrane database of systematic reviews.

[24]  E. Zecca,et al.  Fentanyl Sublingual Tablets Versus Subcutaneous Morphine for the Management of Severe Cancer Pain Episodes in Patients Receiving Opioid Treatment: A Double-Blind, Randomized, Noninferiority Trial. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  P. Hoskin,et al.  Efficacy of single fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review and meta-analysis. , 2017, Annals of palliative medicine.

[26]  J. Gaertner,et al.  Metamizole/dipyrone for the relief of cancer pain: A systematic review and evidence-based recommendations for clinical practice , 2017, Palliative medicine.

[27]  A. Caraceni,et al.  Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project , 2017, Palliative medicine.

[28]  D. Rades,et al.  Radiotherapy With 4 Gy × 5 Versus 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial (ARO 2009/01). , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  E. Bruera,et al.  Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  B. Kremer,et al.  Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer. , 2016, European journal of cancer.

[31]  C. Marcassa,et al.  Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis , 2016, OncoTargets and therapy.

[32]  S. Mercadante,et al.  Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study. , 2016, Journal of pain and symptom management.

[33]  S. Kaasa,et al.  From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations. , 2016, Journal of pain and symptom management.

[34]  Sri Suryawati,et al.  Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study , 2016, The Lancet.

[35]  E. Bruera,et al.  Opioid switching in cancer pain: From the beginning to nowadays. , 2016, Critical reviews in oncology/hematology.

[36]  C. Marcassa,et al.  Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis , 2015, Drug design, development and therapy.

[37]  S. Mercadante,et al.  Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study. , 2015, Journal of pain and symptom management.

[38]  J. Wagner,et al.  Cancer Pain Relief , 2015 .

[39]  A. Hackshaw,et al.  A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer. , 2015, Journal of the National Cancer Institute.

[40]  J. Moyá,et al.  Efficacy and Safety of Oral or Nasal Fentanyl for Treatment of Breakthrough Pain in Cancer Patients: A Systematic Review , 2015, Journal of pain & palliative care pharmacotherapy.

[41]  P. Hoskin,et al.  Stereotactic body radiotherapy for spinal and bone metastases. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[42]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[43]  Blair H. Smith,et al.  Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis , 2015, The Lancet Neurology.

[44]  N. Katakami,et al.  Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial , 2015, International Journal of Clinical Oncology.

[45]  S. Mercadante.  Fentanyl buccal tablet for the treatment of cancer-related breakthrough pain , 2015, Expert review of clinical pharmacology.

[46]  S. Deandrea,et al.  Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  S. Gibson,et al.  Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools , 2014, BMC Geriatrics.

[48]  A. Cuomo,et al.  Efficacy and Gastrointestinal Tolerability of Oral Oxycodone/Naloxone Combination for Chronic Pain in Outpatients With Cancer , 2014, The American journal of hospice & palliative care.

[49]  M. Cowie,et al.  Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients. , 2014, Journal of pain and symptom management.

[50]  P. Wiffen,et al.  Codeine, alone and with paracetamol (acetaminophen), for cancer pain. , 2014, The Cochrane database of systematic reviews.

[51]  W. Leppert,et al.  Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain , 2014, Supportive Care in Cancer.

[52]  P. Skorga,et al.  Transdermal fentanyl for cancer pain. , 2014, Clinical nurse specialist CNS.

[53]  J. Hardy,et al.  Therapeutic Challenges in Cancer Pain Management: A Systematic Review of Methadone , 2014, Journal of pain & palliative care pharmacotherapy.

[54]  P. Farquhar-smith,et al.  Pain in cancer survivors , 2014, British journal of pain.

[55]  A. Kaye,et al.  Availability and utilization of opioids for pain management: global issues. , 2014, The Ochsner journal.

[56]  W. Chey,et al.  Naloxegol for opioid-induced constipation in patients with noncancer pain. , 2014, The New England journal of medicine.

[57]  M. Stubblefield,et al.  Pain in cancer survivors. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  S. Fosså,et al.  Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. , 2014, The Lancet. Oncology.

[59]  M. Jensen,et al.  Psychological and behavioral approaches to cancer pain management. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  Chris Barker,et al.  Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management , 2014, Gastroenterology research and practice.

[61]  Roman Rolke,et al.  Confirming neuropathic pain in cancer patients: Applying the NeuPSIG grading system in clinical practice and clinical research , 2014, PAIN®.

[62]  J. González-Barboteo,et al.  [Use of methadone in the elderly with cancer pain: a systematic review]. , 2014, Revista espanola de geriatria y gerontologia.

[63]  J. Jansen,et al.  A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes. , 2014, Journal of pain and symptom management.

[64]  Bingshu E. Chen,et al.  Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. , 2014, The Lancet. Oncology.

[65]  B. Duthey,et al.  Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006. , 2014, Journal of pain and symptom management.

[66]  M. Bennett,et al.  Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. , 2013, Pain medicine.

[67]  R. Dworkin,et al.  Interventional management of neuropathic pain: NeuPSIG recommendations , 2013, PAIN®.

[68]  M. Bennett,et al.  Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. , 2013, Journal of pain and symptom management.

[69]  Manohar Sharma,et al.  Cordotomy in mesothelioma-related pain: a systematic review , 2013, BMJ Supportive & Palliative Care.

[70]  L. Fallowfield,et al.  Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid , 2013, Supportive Care in Cancer.

[71]  P. Konrad,et al.  Open Thoracic Cordotomy as a Treatment Option for Severe, Debilitating Pain , 2013, Journal of Neurological Surgery—Part A.

[72]  M. Fallon,et al.  An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. , 2013, Journal of pain and symptom management.

[73]  Manohar Sharma,et al.  Percutaneous cervical cordotomy for the management of pain from cancer: a prospective review of 45 cases. , 2013, Journal of palliative medicine.

[74]  S. Mercadante.  Pharmacotherapy for Breakthrough Cancer Pain , 2012, Drugs.

[75]  N. Laperriere,et al.  A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. , 2012, International journal of radiation oncology, biology, physics.

[76]  M. Fallon,et al.  Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. , 2012, The journal of pain : official journal of the American Pain Society.

[77]  J. Bull,et al.  Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study , 2012, Current medical research and opinion.

[78]  Manohar Sharma,et al.  Percutaneous cervical cordotomy for non-cancer pain in a patient with terminal esophageal carcinoma. , 2012, Journal of pain and symptom management.

[79]  M. Hjermstad,et al.  Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review , 2012, PAIN.

[80]  P. Stone,et al.  Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. , 2012, The Lancet. Oncology.

[81]  B. Spring,et al.  Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  D. Rades,et al.  Dose escalation of radiotherapy for Metastatic Spinal Cord Compression (MSCC) in patients with relatively favorable survival prognosis , 2011, Strahlentherapie und Onkologie.

[83]  S. Kaasa,et al.  Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: An EPCRC opioid guidelines project , 2011, Palliative medicine.

[84]  P. Stone,et al.  European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus? , 2011, Palliative medicine.

[85]  M. Bennett.  Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review , 2011, Palliative medicine.

[86]  A. Caraceni,et al.  Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review , 2011, Palliative medicine.

[87]  S. Kaasa,et al.  Starting Step III opioids for moderate to severe pain in cancer patients: Dose titration: A systematic review , 2011, Palliative medicine.

[88]  K. Forbes,et al.  A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: A European Palliative Care Research Collaborative opioid guidelines project , 2011, Palliative medicine.

[89]  R. Portenoy.  Treatment of cancer pain , 2011, The Lancet.

[90]  B. Ferrell,et al.  The management of cancer pain , 2011, CA: a cancer journal for clinicians.

[91]  K. E. Clemens,et al.  Bowel function during pain therapy with oxycodone/naloxone prolonged‐release tablets in patients with advanced cancer , 2011, International journal of clinical practice.

[92]  S. Carrara,et al.  Celiac plexus block for pancreatic cancer pain in adults. , 2011, The Cochrane database of systematic reviews.

[93]  E. Mendel,et al.  Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. , 2011, International journal of radiation oncology, biology, physics.

[94]  M. Carducci,et al.  Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study , 2011, The Lancet.

[95]  J. V. Von Roenn,et al.  American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer. , 2011, Journal of Oncology Practice.

[96]  B. Candy,et al.  Laxatives or methylnaltrexone for the management of constipation in palliative care patients , 2011, The Cochrane database of systematic reviews.

[97]  Y. Fujiwara,et al.  Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  G. Tognoni,et al.  Is pain in patients with haematological malignancies under-recognised? The results from Italian ECAD-O survey. , 2010, Leukemia research.

[99]  L. Radbruch,et al.  Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[100]  M. Fallon,et al.  Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. , 2010, Journal of pain and symptom management.

[101]  M. Fallon,et al.  Opioid-induced hyperalgesia: a clinical challenge. , 2010, British journal of anaesthesia.

[102]  F. De Conno,et al.  Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[103]  M. Bennett,et al.  How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis , 2009, PAIN®.

[104]  S. Mercadante,et al.  Equipotent doses to switch from high doses of opioids to transdermal buprenorphine , 2009, Supportive Care in Cancer.

[105]  N. Magrini,et al.  Prescription of opioids in Italy: everything, but the morphine. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[106]  C. Reid,et al.  The management of cancer‐related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland , 2009, European journal of pain.

[107]  S. Mercadante,et al.  Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. , 2009, Journal of pain and symptom management.

[108]  W. Brugge,et al.  EUS-Guided Celiac Plexus Neurolysis for Pain due to Chronic Pancreatitis or Pancreatic Cancer Pain: A Meta-Analysis and Systematic Review , 2009, Digestive Diseases and Sciences.

[109]  W. Meissner,et al.  A randomised controlled trial with prolonged‐release oral oxycodone and naloxone to prevent and reverse opioid‐induced constipation , 2009, European journal of pain.

[110]  M. Sharma,et al.  The role of epidural phenol in cancer patients at the end of life , 2008, Palliative medicine.

[111]  W. Chambers.  Nerve blocks in palliative care. , 2008, British journal of anaesthesia.

[112]  J. Dostrovsky,et al.  Neuropathic pain , 2008, Neurology.

[113]  M. Narabayashi,et al.  Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial. , 2008, Japanese journal of clinical oncology.

[114]  S. Datta,et al.  Opioid complications and side effects. , 2008, Pain physician.

[115]  B. Ferrell,et al.  Barriers to pain assessment and management in cancer survivorship , 2008, Journal of cancer survivorship : research and practice.

[116]  BTS statement on malignant mesothelioma in the UK, 2007 , 2007, Thorax.

[117]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[118]  H C Schouten,et al.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[119]  A. Burton,et al.  Chronic pain in the cancer survivor: a new frontier. , 2007, Pain medicine.

[120]  Luis Eduardo Bravo,et al.  Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial. , 2007, Journal of palliative medicine.

[121]  D. Tibboel,et al.  Observation Scales for Pain Assessment in Older Adults With Cognitive Impairments or Communication Difficulties , 2007, Nursing research.

[122]  E. Maranzano,et al.  Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  G. Lauretti,et al.  Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients , 2003, British Journal of Cancer.

[124]  V. Kouloulias,et al.  Long‐term cancer pain management in morphine pre‐treated and opioid naive patients with transdermal fentanyl , 2003, International journal of cancer.

[125]  H. Frankish.  15 million new cancer cases per year by 2020, says WHO , 2003, The Lancet.

[126]  F. Fulfaro,et al.  Opioid plasma concentration during switching from morphine to methadone: preliminary data , 2003, Supportive Care in Cancer.

[127]  M. Rajagopal,et al.  Intravenous morphine for rapid control of severe cancer pain , 2003, Palliative medicine.

[128]  D. Tse,et al.  An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population , 2003, Palliative medicine.

[129]  J. Kievit,et al.  Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. , 2003, Journal of the National Cancer Institute.

[130]  S. Kaasa,et al.  Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial , 2003, Pain.

[131]  F. Fulfaro,et al.  Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion , 2002, Cancer.

[132]  P. McNamara.  Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care , 2002, Palliative medicine.

[133]  Augusto Caraceni,et al.  Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. , 2002, Journal of pain and symptom management.

[134]  Management of Cancer Pain Evidence Report Technology Assessment , 2002 .

[135]  C. Dykewicz.  Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[136]  F. Fulfaro,et al.  Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  G. Pasternak,et al.  Strategies to manage the adverse effects of oral morphine: an evidence-based report. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[138]  S. Mercadante,et al.  Opioid poorly-responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. , 2001, Journal of pain and symptom management.

[139]  G. Gourlay.  Treatment of cancer pain with transdermal fentanyl. , 2001, The Lancet. Oncology.

[140]  S. Mercadante.  Opioid rotation for cancer pain , 1999, Cancer.

[141]  S. Mercadante,et al.  Rapid switching from morphine to methadone in cancer patients with poor response to morphine. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[142]  E. Bruera,et al.  Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[143]  C. Brunelli,et al.  Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[144]  E. Kalso,et al.  Controlled-release oxycodone and morphine in cancer related pain , 1997, Pain.

[145]  N. Hagen,et al.  Comparative clinical efficacy and safety of a novel controlled‐release oxycodone formulation and controlled‐release hydromorphone in the treatment of cancer pain , 1997, Cancer.

[146]  E. Kalso,et al.  Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study , 1996, Pain.

[147]  Fortnightly Review: Morphine in cancer pain: modes of administration , 1996 .

[148]  M. Tryba,et al.  Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain , 1996, Pain.

[149]  K. Foley,et al.  Opioid pharmacotherapy in the management of cancer pain. A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration , 1995, Cancer.

[150]  F. Mosteller,et al.  Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[151]  T. Lamer,et al.  Treatment of cancer-related pain: when orally administered medications fail. , 1994, Mayo Clinic proceedings.

[152]  C. Cleeland,et al.  Pain and its treatment in outpatients with metastatic cancer. , 1994, The New England journal of medicine.

[153]  R. Portenoy,et al.  Breakthrough pain: definition, prevalence and characteristics , 1990, Pain.

[154]  E. Kalso,et al.  Morphine and oxycodone hydrochloride in the management of cancer pain , 1990, Clinical pharmacology and therapeutics.

[155]  A. Vainio,et al.  Opioid treatment for radiating cancer pain: oral administration vs. epidural techniques , 1988, Acta anaesthesiologica Scandinavica.

[156]  R. Kaiko,et al.  The Therapeutic Equivalence of IM and PO Administration of Morphine – 1:3 or 1:6? , 1988, Journal of palliative care.

[157]  K. Foley.  Cancer pain syndromes. , 1987, Journal of pain and symptom management.

[158]  A. Caraceni,et al.  A validation study of the WHO method for cancer pain relief , 1987, Cancer.

[159]  T. Hedner,et al.  Pharmacokinetic Aspects of Intrathecal Morphine Analgesia , 1984, Anesthesiology.

[160]  D. Doyle.  Nerve blocks in advanced cancer. , 1982, The Practitioner.

[161]  M. Bennett,et al.  Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis , 2018, Palliative medicine.

[162]  J. Petit,et al.  Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. , 2017, Practical radiation oncology.

[163]  E. Bruera,et al.  2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer , 2016, Supportive Care in Cancer.

[164]  S. Deandrea,et al.  Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. , 2014, Journal of pain and symptom management.

[165]  P. Wiffen,et al.  Oral morphine for cancer pain. , 2013, The Cochrane database of systematic reviews.

[166]  M. Bennett,et al.  Spinal cord stimulation for cancer-related pain in adults. , 2013, The Cochrane database of systematic reviews.

[167]  M. van Kleef,et al.  Evidence-Based Interventional Pain Medicine According to Clinical Diagnoses 23. Pain in Patients with Cancer , 2011 .

[168]  C. Brunelli,et al.  Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[169]  R. Gooberman-Hill,et al.  Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[170]  A. Wells,et al.  No pain relief from morphine? , 2005, Supportive Care in Cancer.

[171]  E. Bruera,et al.  Cancer pain : assessment and management , 2003 .

[172]  A. Miller,et al.  A RANDOMISED CROSSOVER COMPARISON OF CONTROLLED RELEASE HYDROMORPHONE TABLETS WITH CONTROLLED RELEASE MORPHINE TABLETS IN PATIENTS WITH CANCER PAIN , 1999 .